Tadej Pogacar has essentially sewn up this year’s Tour de France - but what’s it like running one of the teams trying to ...
From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites ...
HLB's hopes of bringing its liver cancer treatment to the US market have suffered another blow after the US Food and Drug ...
Econostrum on MSN
FDA recalls thousands of cholesterol drug bottles nationwide after manufacturing deviations
The U.S. Food and Drug Administration (FDA) has classified a nationwide recall involving 3,648 bottles of fenofibrate, a ...
HLB's liver cancer drug rivoceranib has again failed to clear the US Food and Drug Administration, receiving a complete ...
A new study published in The Lancet Public Health journal reveals that almost all countries are overusing 'watch' class ...
28d
More than 11,000 bottles of blood pressure medication recalled due to manufacturing issue, FDA says
Thousands of bottles of blood pressure medication are being pulled nationwide because of a manufacturing issue.
Utah has a lower rate of people under "correctional control" than much of the nation but spends more per inmate each year ...
Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and financial improvements.
Some microorganisms that hold great promise for research have long lain dormant in historical collections. But only through ...
On the 15th, HLB announced that the general cGMP inspection of the manufacturing site of rivoceranib's active pharmaceutical ingredient (API), which w ...
Morning Overview on MSN
A heart-failure drug was pulled after foreign material turned up in the tablets
Patients who depend on a heart-failure medication to manage a chronic and potentially life-threatening condition lost access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results